Search results

Jump to navigation Jump to search

Page title matches

  • ...ct through brain catecholamine systems. A third group ([[second-generation antidepressant]] agents) is a diverse group of drugs including some that act specifically {{main|Tricyclic antidepressant}}
    7 KB (937 words) - 11:55, 21 October 2011
  • #Redirect [[Second-generation antidepressant]]
    46 bytes (3 words) - 15:15, 15 May 2008
  • #Redirect [[Second-generation antidepressant]]
    46 bytes (3 words) - 15:16, 15 May 2008
  • 137 bytes (16 words) - 15:27, 17 May 2008
  • ...n, adrenergic, and [[histamine]] receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to ...Gilman's The Pharmacological Basis of Therapeutics |edition=11th |chapter=Antidepressant Agents |chapterurl= |language= |publisher=McGraw-Hill |location=New York |y
    5 KB (622 words) - 14:32, 2 February 2023
  • ...o treat depression. They are characterized by dissimilarity to [[tricyclic antidepressant]]s and [[monoamine oxidase inhibitor]]s, and heterogeneity of chemical form ===Noradrenergic and specific serotonergic antidepressant (NaSSA)===
    11 KB (1,448 words) - 14:12, 2 February 2023
  • ...the two drug classes used widely to treat [[depression]], the [[tricyclic antidepressant]]s and the [[monoamine oxidase inhibitor]]s (MAOI), and heterogeneity of ch
    1 KB (204 words) - 19:25, 29 January 2010
  • 12 bytes (1 word) - 21:53, 5 March 2008
  • 12 bytes (1 word) - 23:00, 6 March 2008
  • 244 bytes (26 words) - 16:35, 14 October 2010
  • Auto-populated based on [[Special:WhatLinksHere/Antidepressant]]. Needs checking by a human. {{r|Second-generation antidepressant}}
    798 bytes (96 words) - 10:58, 11 January 2010
  • 186 bytes (23 words) - 11:11, 8 September 2009
  • ...cally effective drug classes used to treat [[depression]], the [[tricyclic antidepressant]]s and [[monoamine oxidase inhibitor]]s, the former still in substantial us
    245 bytes (32 words) - 19:16, 29 January 2010
  • Auto-populated based on [[Special:WhatLinksHere/Tricyclic antidepressant]]. Needs checking by a human. {{r|Antidepressant}}
    719 bytes (86 words) - 21:05, 11 January 2010

Page text matches

  • ...pressant]]s, with generally improved side effect profiles over [[tricyclic antidepressant]]s and [[monoamine oxidase inhibitor]]s
    210 bytes (25 words) - 22:24, 21 August 2010
  • ...s who also suffer from [[tardive dyskinesia]] in preference to [[tricyclic antidepressant]]s, which aggravate this condition. (adapted from [[Medical Subject Heading
    414 bytes (50 words) - 10:09, 17 April 2010
  • Auto-populated based on [[Special:WhatLinksHere/Tricyclic antidepressant]]. Needs checking by a human. {{r|Antidepressant}}
    719 bytes (86 words) - 21:05, 11 January 2010
  • #REDIRECT [[Antidepressant]]
    28 bytes (2 words) - 20:27, 20 July 2011
  • #REDIRECT [[Antidepressant]]
    28 bytes (2 words) - 20:29, 20 July 2011
  • #Redirect [[Second-generation antidepressant]]
    46 bytes (3 words) - 15:15, 15 May 2008
  • #Redirect [[Second-generation antidepressant]]
    46 bytes (3 words) - 15:15, 15 May 2008
  • #Redirect [[Second-generation antidepressant]]
    46 bytes (3 words) - 15:15, 15 May 2008
  • #Redirect [[Second-generation antidepressant]]
    46 bytes (3 words) - 15:16, 15 May 2008
  • #Redirect [[Second-generation antidepressant]]
    46 bytes (3 words) - 15:16, 15 May 2008
  • Second-generation antidepressant agent.
    75 bytes (6 words) - 13:47, 20 November 2011
  • First class of antidepressant medications developed.
    88 bytes (9 words) - 03:45, 19 November 2011
  • {{r|Second-generation antidepressant}} {{r|Tricyclic antidepressant}}
    368 bytes (39 words) - 18:21, 14 October 2010
  • A [[second-generation antidepressant]], which is a [[serotonin uptake inhibitor]]
    117 bytes (12 words) - 10:57, 10 February 2010
  • {{r|Antidepressant}} {{r|Second-generation antidepressant}}
    1 KB (160 words) - 13:27, 17 May 2016
  • Auto-populated based on [[Special:WhatLinksHere/Antidepressant]]. Needs checking by a human. {{r|Second-generation antidepressant}}
    798 bytes (96 words) - 10:58, 11 January 2010
  • <noinclude>{{Subpages}}</noinclude>A drug of the [[tricyclic antidepressant]] group, with a wide range of applications beyond [[mental health]], especi
    178 bytes (23 words) - 17:48, 20 October 2010
  • * [[Tricyclic antidepressant]] in medicine
    170 bytes (19 words) - 12:19, 31 May 2009
  • ...cally effective drug classes used to treat [[depression]], the [[tricyclic antidepressant]]s and [[monoamine oxidase inhibitor]]s, the former still in substantial us
    245 bytes (32 words) - 19:16, 29 January 2010
  • Antidepressant that selectively inhibits the uptake of serotonin in the brain, used in the
    158 bytes (21 words) - 11:23, 8 September 2009
  • {{r|Second-generation antidepressant||**}}
    352 bytes (41 words) - 10:14, 17 April 2010
  • ...on antidepressant]] agent. Mirtazapine is also classified as a [[tricyclic antidepressant]] by the [[National Library of Medicine]] in the [[United States of America Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA).<ref name="pmid22161405">{{cite journal| author=Watanabe N, Omori I
    3 KB (422 words) - 14:08, 2 February 2023
  • {{r|Antidepressant}} {{r|Tricyclic antidepressant||**}}
    3 KB (368 words) - 14:03, 1 April 2024
  • In [[medicine]], '''paroxetine''' is a [[second-generation antidepressant]] used for treating [[major depression]]. Its pharmacological action is a [ ...erally have not shown effectiveness in [[chronic pain]], while [[tricyclic antidepressant]]s often are useful, paroxetine has been compared to the tricyclic [[imipra
    2 KB (279 words) - 11:00, 10 February 2010
  • {{r|Second-generation antidepressant}}
    589 bytes (65 words) - 15:17, 3 August 2009
  • ...axon terminals or into storage vesicles within terminals. The [[tricyclic antidepressant]]s and [[amphetamine]]s are among the therapeutically important drugs that ...or= |others= |title=Basic and Clinical Pharmacology |edition=10th |chapter=Antidepressant Agents |chapterurl= |language= |publisher=McGraw-Hill Medical Publishing Di
    2 KB (209 words) - 07:51, 9 September 2009
  • '''Monoamine oxidase inhibitors''' (MAOIs) were the first class of [[antidepressant]] medications developed. MAOIs increase levels of monoamine neurotransmitte ...ith.edu/departments/Biochem/Chm_357/Articles/MAOIREV.pdf Half a Century of Antidepressant Drugs: On the Clinical Introduction of Monoamine Oxidase Inhibitors]
    2 KB (238 words) - 20:21, 18 January 2010
  • {{r|Tricyclic antidepressant}}
    508 bytes (63 words) - 14:01, 24 January 2011
  • ...s who also suffer from [[tardive dyskinesia]] in preference to [[tricyclic antidepressant]]s, which aggravate this condition. <ref> {{MeSH}}</ref> ...treatment). Cost-effectiveness information is also needed in the field of antidepressant trials. Furthermore, as with most standard systematic reviews, the findings
    4 KB (501 words) - 13:18, 2 February 2023
  • ...n, adrenergic, and [[histamine]] receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to ...Gilman's The Pharmacological Basis of Therapeutics |edition=11th |chapter=Antidepressant Agents |chapterurl= |language= |publisher=McGraw-Hill |location=New York |y
    5 KB (622 words) - 14:32, 2 February 2023
  • {{r|Tricyclic antidepressant}}
    474 bytes (59 words) - 07:45, 8 January 2010
  • {{r|Second-generation antidepressant}}
    540 bytes (67 words) - 20:18, 11 January 2010
  • {{r|Antidepressant}}
    504 bytes (61 words) - 15:55, 11 January 2010
  • {{r|Second-generation antidepressant}}
    594 bytes (73 words) - 20:28, 11 January 2010
  • {{r|Antidepressant}}
    586 bytes (73 words) - 20:18, 11 January 2010
  • {{r|Antidepressant}}
    928 bytes (114 words) - 21:45, 19 September 2009
  • In [[medicine]], '''sertraline''' is a [[second-generation antidepressant]] that is a "[[selective serotonin uptake inhibitor]] that is used in the t
    784 bytes (100 words) - 14:12, 2 February 2023
  • {{r|Antidepressant}}
    657 bytes (82 words) - 18:58, 11 January 2010
  • ...ting generally improved side effects over the first-generation [[tricyclic antidepressant]]s and [[monoamine oxidase inhibitor]]s.
    3 KB (345 words) - 09:46, 13 February 2011
  • {{r|Antidepressant}}
    775 bytes (100 words) - 19:42, 11 January 2010
  • {{r|Second-generation antidepressant}}
    796 bytes (99 words) - 10:52, 11 January 2010
  • {{r|Tricyclic antidepressant}}
    765 bytes (90 words) - 19:22, 11 January 2010
  • ...ct through brain catecholamine systems. A third group ([[second-generation antidepressant]] agents) is a diverse group of drugs including some that act specifically {{main|Tricyclic antidepressant}}
    7 KB (937 words) - 11:55, 21 October 2011
  • {{r|Tricyclic antidepressant}}
    885 bytes (112 words) - 17:13, 11 January 2010
  • {{r|Antidepressant}}
    926 bytes (114 words) - 15:48, 11 January 2010
  • ...econd-generation antidepressant|second-generation]] and [[first-generation antidepressant]]s.
    3 KB (410 words) - 11:51, 2 February 2023
  • {{r|Antidepressant}}
    884 bytes (109 words) - 19:35, 11 January 2010
  • {{r|Antidepressant}}
    978 bytes (121 words) - 18:12, 11 January 2010
  • '''Bupropion''' is a [[medication]] that is "a unicyclic, aminoketone antidepressant. The mechanism of its therapeutic actions is not well understood, but it do
    1 KB (163 words) - 14:10, 9 October 2009
  • ===Tricyclic antidepressant=== ...fampra/cmp089 }} </ref> However, several randomized controlled trials of [[antidepressant agent]]s included in the systematic review were positive.
    6 KB (838 words) - 21:18, 4 June 2012
  • {{r|Tricyclic antidepressant}}
    1 KB (150 words) - 19:29, 11 January 2010
  • In [[psychiatry]], '''citalopram''' is a [[second-generation antidepressant]] for treating [[major depressive disorder]].
    1 KB (123 words) - 11:44, 2 February 2023
  • {{r|Antidepressant}}
    1 KB (190 words) - 04:39, 24 February 2010
  • ...axon terminals or into storage vesicles within terminals. The [[tricyclic antidepressant]]s (tricyclic antidepressive agents) and amphetamines are among the therape
    1 KB (159 words) - 04:09, 30 September 2009
  • ...ne]] and [[neuropharmacology]], '''venlafaxine''' is a [[second generation antidepressant]] that has unusual chemistry: it inhibits the reuptake of several [[neurotr ...nd comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. | journal = J Clin Psychopharmacol | year = 20
    3 KB (390 words) - 14:34, 2 February 2023
  • '''Amitryptyline''' is a drug of the [[tricyclic antidepressant]] group, with a wide range of applications beyond [[mental health]], especi ...fampra/cmp089 }} </ref> However, several randomized controlled trials of [[antidepressant agent]]s included in the systematic review were positive.
    3 KB (455 words) - 18:36, 20 October 2010
  • ...the two drug classes used widely to treat [[depression]], the [[tricyclic antidepressant]]s and the [[monoamine oxidase inhibitor]]s (MAOI), and heterogeneity of ch
    1 KB (204 words) - 19:25, 29 January 2010
  • ...o treat depression. They are characterized by dissimilarity to [[tricyclic antidepressant]]s and [[monoamine oxidase inhibitor]]s, and heterogeneity of chemical form ===Noradrenergic and specific serotonergic antidepressant (NaSSA)===
    11 KB (1,448 words) - 14:12, 2 February 2023
  • ...gs that inhibit the [[cytochrome P-450]] CYP2D6 and CYP3A4 metabolism of [[antidepressant]]s may increase the risk.<ref name="pmid15784664"/>
    4 KB (592 words) - 19:49, 16 August 2016
  • | title = Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipola
    2 KB (236 words) - 11:50, 2 February 2023
  • ...nal |author=Mourad I, Lejoyeux M, Adès J |title=[Prospective evaluation of antidepressant discontinuation] |language=French |journal=L'Encéphale |volume=24 |issue=3
    4 KB (553 words) - 21:20, 19 February 2010
  • ...|others= |title=Basic and Clinical Pharmacology |edition=10th |chapter=30. Antidepressant agents |chapterurl= |language= |publisher=McGraw-Hill Medical Publishing Di
    2 KB (253 words) - 12:24, 2 October 2013
  • ...te being quite dissimilar chemically. It is also similar to the tricyclic antidepressant medications.<ref>{{cite web|url=http://www.drugbank.ca/cgi-bin/getCard.cgi?
    2 KB (230 words) - 12:47, 6 April 2009
  • {{r|Second-generation antidepressant}}
    2 KB (310 words) - 12:22, 18 April 2024
  • Early [[tricyclic antidepressant]]<ref name="pmid9204652">{{cite journal| author=Bowsher D| title=The effect ...re are a number of therapies. Comparative studies suggest that [[tricyclic antidepressant]]s such as [[desipramine]]<ref name=>{{citation | journal= Journal of the
    7 KB (1,019 words) - 08:48, 17 March 2011
  • ...energic beta-antagonist|adrenergic receptor antagonist]]s; and [[tricyclic antidepressant]]s. This enzyme is deficient in up to 10 percent of the Caucasian populatio
    3 KB (483 words) - 17:34, 10 February 2024
  • .../cite&retmode=ref&cmd=prlinks&id=8159194 }} </ref> or [[second-generation antidepressant]]s<ref name="pmid20332772">{{cite journal| author=Lee H, Kim JH, Min BH,
    8 KB (1,069 words) - 12:25, 5 June 2014
  • ...''Br J Psychiatry'' 190:287-92. PMID 17401033 ''"Follow-up assessments in antidepressant treatment trials incur a significant therapeutic effect for participants on
    9 KB (1,201 words) - 12:30, 2 October 2013
  • {{r|Antidepressant}}
    4 KB (486 words) - 19:46, 11 January 2010
  • [[Second-generation antidepressant]]s ([[paroxetine]], [[venlafaxine]], [[fluoxetine]]) and [[gabapentin]] may
    3 KB (462 words) - 10:14, 12 July 2011
  • ...yndrome]]. It may, however, be lower in cardiac risk than some [[tricyclic antidepressant]]s such as [[imipramine]]. There are also potential interactions with [[or
    4 KB (516 words) - 00:39, 2 February 2011
  • ...n to [[opioid analgesic]]s and other drugs used in chronic pain, such as [[antidepressant]]s and [[anticonvulsant]]s, regional sympathetic nerve blocks may be helpfu
    4 KB (548 words) - 17:33, 12 March 2011
  • ...n A, Redding N, Brown WA (2008) The persistence of the placebo response in antidepressant clinical trials. ''J Psychiatr Res'' 42791-6 PMID 18036616 ''Our objective
    5 KB (669 words) - 12:44, 2 October 2013
  • ...clinician prescribes an appropriate dose of a drug, such as a [[tricyclic antidepressant]], the pharmacological effect of which is known to start only after several ...ffect is unexpected, as in the case of immediate response to the tricyclic antidepressant, it cannot simply be stopped. Should the potential dangers of such a pharma
    17 KB (2,626 words) - 14:09, 2 February 2023
  • ...enosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized cl {{main|Second-generation antidepressant|Antidepressant}}
    32 KB (4,377 words) - 13:17, 2 February 2023
  • ...AbstractPlus&list_uids=15652395&query_hl=19&itool=pubmed_docsum (7)] and [[antidepressant]] and anxiety (anxiolytic)-like behaviors in rats [http://www.ncbi.nlm.nih.
    6 KB (907 words) - 04:52, 17 October 2013
  • ...agents may improve the symptoms of fibromyalgia patients. These include [[antidepressant]]s, [[analgesic]]s, [[anticonvulsant]]s, [[muscle relaxant]]s, and sedative ...="pmid10749947">{{cite journal |author=Arnold LM, Keck PE, Welge JA |title=Antidepressant treatment of fibromyalgia. A meta-analysis and review |journal=Psychosomati
    25 KB (3,339 words) - 07:16, 2 July 2014
  • ...ews AM, Linardatos E, Tell RA, Rosenthal R |title=Selective publication of antidepressant trials and its influence on apparent efficacy |journal=N. Engl. J. Med. |vo ...tle = Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications
    28 KB (3,923 words) - 14:09, 2 February 2023
  • ...em of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. | journal=Arch Gen Psy
    7 KB (965 words) - 16:45, 19 October 2013
  • ...rapy051html.htm]</ref>. It is also used in cases of severe depression when antidepressant medication, psychotherapy, or both, have been ineffective, when medication ...sustain the response to ECT, continuation treatment, often in the form of antidepressant and/or mood stabilizer medication, is used. "Maintenance ECT" refers to ind
    23 KB (3,486 words) - 05:29, 2 August 2011
  • ...on owing to impaired cerebral lateralization. Therapeutically, too, better antidepressant results are obtained with non-dominant unilateral electroconvulsive shock.
    8 KB (1,104 words) - 23:20, 19 February 2010
  • ...ews AM, Linardatos E, Tell RA, Rosenthal R |title=Selective publication of antidepressant trials and its influence on apparent efficacy |journal=N. Engl. J. Med. |vo ...ews AM, Linardatos E, Tell RA, Rosenthal R| title=Selective publication of antidepressant trials and its influence on apparent efficacy. | journal=N Engl J Med | yea
    32 KB (4,430 words) - 08:23, 27 September 2012
  • ...al of Paediatric Health Care'' 23:4 pp.206-212 (''Originally studied as an antidepressant, sibutramine is a serotonin and norepinephrine re-uptake inhibitor, with me
    10 KB (1,390 words) - 07:46, 19 December 2010
  • ...ant]]s may be effective and may be more effective than [[second-generation antidepressant]]s according to a [[systematic review]].<ref name="pmid20961988">{{cite jou
    26 KB (3,466 words) - 20:38, 20 March 2014
  • ...ith behavior modification but extreme behaviours may require medication. [[Antidepressant]]s have been shown to improve some symptoms.<ref name=NIDS/>
    11 KB (1,654 words) - 09:12, 31 August 2010
  • {{main|Antidepressant}} ...K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J et al.| title=Optimized antidepressant therapy and pain self-management in primary care patients with depression a
    25 KB (3,650 words) - 02:18, 7 April 2024
  • * [[Antidepressant]] * [[Second-generation antidepressant]]
    21 KB (2,958 words) - 05:06, 8 March 2024
  • *[[Antidepressant]]s are an important and often overlooked tool in the treatment of mastocyto
    13 KB (1,802 words) - 09:02, 1 March 2024
  • ...ety and depression judged the benzodiazepines, especially combined with an antidepressant, as the mainstays of pharmacotherapy for anxiety disorders.<ref>Uhlenhuth E
    13 KB (1,788 words) - 18:38, 5 May 2014
  • .... Drugs can be given to aid relaxation, such as [[tricyclic]]s which are [[antidepressant]] medications, and [[benzodiazapines]] as well.
    14 KB (2,135 words) - 13:16, 2 February 2023
  • ...tients with [[major depression]]; b) are similarly effective as standard [[antidepressant]]s; c) and have fewer side effects than standard antidepressants. The assoc
    17 KB (2,485 words) - 17:34, 10 February 2024
  • Amphetamines are sometimes used to augment [[antidepressant]] therapy in treatment-resistant [[depression]].
    16 KB (2,210 words) - 17:32, 10 February 2024
  • ...noradrenaline reuptake inhibitors (both are classes of [[second-generation antidepressant]]s).<ref name="pmid21398351">{{cite journal| author=Baldwin D, Woods R, Law
    19 KB (2,612 words) - 08:23, 3 December 2013
  • Poor metabolism affects many [[antidepressant]]s, [[metoprolol]] and other drugs that use this [[isoenzyme]]. Some narcot
    22 KB (2,960 words) - 17:35, 10 February 2024
  • ...te journal |author=Salerno SM, Browning R, Jackson JL |title=The effect of antidepressant treatment on chronic back pain: a meta-analysis |journal=Arch. Intern. Med.
    47 KB (6,751 words) - 13:16, 2 February 2023
  • ...sychiatry'', 185: 31-36 PMID 15231553</ref> Clomipramine is a [[tricyclic antidepressant]] that is helpful with both depression and obsessional disorders. In a stu
    22 KB (3,022 words) - 17:02, 21 March 2024
  • Agents for pain control include [[tricyclic antidepressant]]s (TCAs), [[serotonin reuptake inhibitor]]s (SSRIs) and antiepileptic drug
    23 KB (3,280 words) - 09:09, 1 March 2024
  • ...V, Muris J, Rubin G, de Wit N | title = Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. | journal = Cochr ...roenke K | title = Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. | journal = Am J Med | volume = 108 | issue =
    70 KB (9,828 words) - 17:34, 10 February 2024
  • ...ttp://www.findarticles.com/p/articles/mi_m1175/is_4_35/ai_91752194 | title=Antidepressant drug trials: fast track to overprescription? | accessdate=2006-03-16}}</ref
    33 KB (4,783 words) - 18:49, 30 April 2024
  • ..., Kroenke K |title=Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis |journal=Am. J. Med. |volume=108 |issue=1 |pag
    39 KB (5,137 words) - 10:07, 28 February 2024
  • ...= 347 | issue= 8995 | pages= 143-7 | pmid=8544547 }} </ref> or [[tricyclic antidepressant]].<ref name="pmid12370455">{{cite journal| author=Raja SN, Haythornthwaite
    42 KB (5,794 words) - 14:08, 2 February 2023
  • ...uch as fluoxetine, or, in pure depression, [[sertraline]]. The [[tricyclic antidepressant]] [[amitriptyline]] may help both depression and chronic pain.
    52 KB (7,594 words) - 17:09, 21 March 2024
  • .../cgi/pmidlookup?view=long&pmid=11710893 |issn=}}</ref> This affects many [[antidepressant]]s, [[metoprolol]] and other drugs that use this [[isoenzyme]]. More inform
    81 KB (10,863 words) - 17:35, 10 February 2024